CALL SPRINTER OPEN END - GILEAD SCIENCES Share Price

Certificat

OGIAEV

CH0567309072

Market Closed - Swiss Exchange 16:20:00 14/06/2024 BST
0.46 CHF +9.52% Intraday chart for CALL SPRINTER OPEN END - GILEAD SCIENCES
Current month+12.20%
1 month-23.33%
Date Price Change
14/06/24 0.46 +9.52%
13/06/24 0.42 -2.33%
12/06/24 0.43 -2.27%
10/06/24 0.44 -2.22%

Delayed Quote Swiss Exchange

Last update June 14, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
IssuerLogo Issuer Vontobel Vontobel
OGIAEV
ISINCH0567309072
Date issued 10/09/2020
Strike 54.65 $
Maturity Unlimited
Parity 20 : 1
Emission price 0.66 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 1.77 CHF
Lowest since issue 0.32 CHF
Spread 0.01 CHF
Spread %2.13%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
65.06 USD
Average target price
82.7 USD
Spread / Average Target
+27.11%
Consensus
  1. Stock Market
  2. Certificates
  3. OGIAEV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW